Sun Pharmaceutical Industries submits analyst meet intimation

17 Oct 2023 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed press release relating to Earnings Call for financial results for the second quarter ending September 30, 2023.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1827.00 -10.30 (-0.56%)
09-Jan-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.00
Dr. Reddys Lab 1371.60
Cipla 1491.70
Lupin 2250.40
Zydus Lifesciences 1009.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.